Download Our NEW Mobile App!
1030 President Avenue, Fall River, MA 02720 | Phone: (508) 675-5858 | Mon-Fri 8:30am - 5:30pm | Sat 9:00am - 2:00pm | Sun Closed

Get Healthy!

  • Posted April 9, 2025

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Health News is provided as a service to Health Care Pharmacy site users by HealthDay. Health Care Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags